A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003
NCT01725594
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemia
Interventions
DRUG:
CAT 2003
DRUG:
Placebo
Sponsor
Catabasis Pharmaceuticals